Company intelligence / Profile preview

Macure Pharma

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Macure Pharma is a privately owned specialty pharmaceutical company focused on the acquisition, development, in-licensing, and distribution of niche hospital pharmaceuticals across Northern and Western Europe. The company does not appear to have a traditional clinical pipeline but instead markets existing or acquired products for specialized healthcare needs.[2][3][5]

Therapeutic areas: Other
Modalities: Small molecules (inferred from focus on hospital pharmaceuticals; no evidence of biologics or advanced therapies)[5][3]
Industry: Biotech

Drug pipeline

1 asset

mexiletine

Commercial

Indications: Non-dystrophic myotonic disorders

Beyond the preview

Go deeper on Macure Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macure Pharma.

Explore the full profile